PMID: 32980496 Malfait F, Symoens S, Goemans N, Gyftodimou Y, Holmberg E, Lpez-Gonzlez V, Mortier G, Nampoothiri S, Petersen MB, De Paepe A
doi: 10.3389/fphar.2020.00967 Received 17 March 2020 Accepted 15 June 2020 Published 30 June 2020 Volume 11 - 2020 Edited by Keizo Kanasaki, Shimane University, Japan Reviewed by Shinji Kume, Shiga University of Medical Science, Japan
The news: The FDA this week issued 30 warning letters to telehealth companies selling compounded GLP-1 weight loss drugs over false or misleading marketing claims
While GLP-1 medications can offer significant benefits for weight management and diabetes control, they may not be suitable for everyone
GrimeliusL , Capella C, Buffa R, Polak JM, Pearse AG, Solcia E
Investigate chromatin structure and nuclear function , focusing on how Epithalon influences DNA organization and cell cycle regulation